Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DMCM) is the leading cause of mortality and morbidity among diabetic patients. DMCM is characterized by an increase in oxidative stress with systemic inflammation that leads to cardiac fibrosis, ultimately causing diastolic and systolic dysfunction. Even though DMCM pathophy...
Main Authors: | Amit K. Rai, Brooke Lee, Ramesh Gomez, Deepu Rajendran, Mahmood Khan, Venkata Naga Srikanth Garikipati |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2020.612722/full |
Similar Items
-
The Role of Non-Coding RNAs in Glioma
by: Anshika Goenka, et al.
Published: (2022-08-01) -
Pathophysiology and Clinical Utility of Non-coding RNAs in Epilepsy
by: Yiye Shao, et al.
Published: (2017-08-01) -
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
by: Seyed Mojtaba Mousavi, et al.
Published: (2022-03-01) -
Non-Coding RNA Networks in Pulmonary Hypertension
by: Hongbin Zang, et al.
Published: (2021-11-01) -
The Role of Non-Coding RNAs in the Neuroprotective Effects of Glutathione
by: Chisato Kinoshita, et al.
Published: (2021-04-01)